Tibial Periosteal Distraction Technique Promotes Diabetic Foot Ulcer Healing and Improves Limb Preservation Rates: A Multicentre Cohort Study
Tibiale Periost-Distractionstechnik fördert die Heilung diabetischer Fußulzera und verbessert die Extremitätenerhaltungsrate: multizentrische Kohortenstudie
Wound Repair and Regeneration · 2026-11 · 34 (6)
DOI: 10.1111/wrr.70216 ↗Auf einen Blick
Bei 249 Patient:innen mit fortgeschrittenen ischämischen diabetischen Fußulzera war tibiale Periost-Distraction mit kürzerer Heilungszeit und besseren Extremitätenergebnissen verbunden als die Standardbehandlung.
Fragestellung
Verbessert tibiale Periost-Distraction bei fortgeschrittenen ischämischen diabetischen Fußulzera die limbbezogenen Outcomes gegenüber der Standardbehandlung?
Methode
Multizentrische retrospektive Kohortenstudie in 3 Zentren; 340 Patient:innen zwischen Januar 2023 und Juni 2025, 249 analysiert. Vergleich von tibialer Periost-Distraction mit Standard-Wundversorgung und Revaskularisation.
Ergebnisse
Heilungszeit: 26 vs. 45 Tage; Major-Amputation: 35,5 % vs. 64,8 %; RR 0,55 (95 %-KI 0,41–0,74); Rezidiv: 2,8 % vs. 20,4 %; RR 0,14 (95 %-KI 0,04–0,43).
Einschränkungen
Retrospektive Kohortenstudie; die Autor:innen nennen prospektive kontrollierte Studien zur Bestätigung der Ergebnisse.
Schlussfolgerung der Autor:innen
Die Autor:innen schlussfolgern, dass tibiale Periost-Distraction mit besseren limbbezogenen Outcomes als die Standardbehandlung assoziiert war.
Kernaussagen
- Kürzere mediane Heilungszeit unter tibialer Periost-Distraction
- Weniger Major-Amputationen und weniger Rezidive
- Prospektive kontrollierte Studien zur Bestätigung erforderlich
Deutsche Zusammenfassung: KI-gestützt aus dem Original-Abstract erstellt; alle Zahlen wurden automatisch mit dem Original abgeglichen. Maßgeblich ist der Original-Abstract.
Kurz gefasst
Multizentrische Studie in der Zeitschrift Wound Repair and Regeneration, online erschienen am 03.11.2026. Verfasst von Le Qiu und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Burns, The First Affiliated Hospital of Anhui Medical University, Hefei, China. Hauptthemen laut MEDLINE: Diabetic Foot, Wound Healing, Tibia, Periosteum. Die Arbeit nennt 29 Literaturangaben. Gefördert von: National Natural Science Foundation of China, Clinical and Translational Research Project of Anhui Province, Clinical Research Project of Anhui University of Traditional Chinese Medicine.
Themen: Diabetisches Fußsyndrom
Abstract (Originalsprache)
Tibial periosteal distraction has emerged as a potential surgical approach for ischemic diabetic foot ulcers, but evidence from large multicentre cohorts remains limited. This multicentre retrospective cohort study aimed to evaluate whether tibial periosteal distraction improves limb‐related outcomes compared with standard treatment in patients with advanced ischemic diabetic foot ulcers. Between January 2023 and June 2025, 340 patients with diabetic foot ulcers were treated at three centres. After applying predefined inclusion and exclusion criteria, 249 patients were eligible for analysis: 107 underwent tibial periosteal distraction and 142 received standard wound care and revascularization procedures. Baseline characteristics were similar between groups. Primary outcomes were ulcer healing time, major amputation, and recurrence. Computed tomography angiography and histopathology were used to evaluate vascular and tissue changes. Tibial periosteal distraction was associated with significantly shorter median healing time (26 vs. 45 days; p < 0.001), lower major amputation rate (35.5% vs. 64.8%; RR 0.55 [95% CI 0.41–0.74]; p < 0.001), and lower recurrence rate (2.8% vs. 20.4%; RR 0.14 [95% CI 0.04–0.43]; p < 0.001) compared with standard treatment. TPD significantly shortened ulcer healing time ( B = 36.485, p < 0.001) and reduced amputation risk (OR = 0.291, p < 0.001) in patients with diabetic foot ulcers. Computed tomography angiography revealed enhanced collateral formation, and histopathologic examination showed morphological changes suggestive of increased vascularity in limbs treated with tibial periosteal distraction. In this multicentre retrospective cohort, tibial periosteal distraction was associated with improved limb‐related outcomes compared with standard treatment. Prospective controlled studies are needed to confirm these findings.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Burns, The First Affiliated Hospital of Anhui Medical University, Hefei, China.
- Anhui Medical University, Hefei, China.
- Department of Emergency Surgery, The First Affiliated Hospital of Anhui Chinese Medical University, Hefei, China.
- Department of Burns and Plastic Surgery, Taihe County People's Hospital, Fuyang, China.
ORCID-Profile: Le Qiu
Förderung
- National Natural Science Foundation of China
- Clinical and Translational Research Project of Anhui Province
- Clinical Research Project of Anhui University of Traditional Chinese Medicine
Zitieren
APA
Qiu, L., Liu, Y., Zhao, Y. P., Zhu, Y. Q., Yan, Y., Jiang, Z. H., Liang, X., Liu, S., Li, F., Sun, Y. X., & Chen, X. L. (2026). Tibial Periosteal Distraction Technique Promotes Diabetic Foot Ulcer Healing and Improves Limb Preservation Rates: A Multicentre Cohort Study. Wound Repair and Regeneration, 34(6). https://doi.org/10.1111/wrr.70216
Vancouver
Qiu L, Liu Y, Zhao YP, Zhu YQ, Yan Y, Jiang ZH, et al. Tibial Periosteal Distraction Technique Promotes Diabetic Foot Ulcer Healing and Improves Limb Preservation Rates: A Multicentre Cohort Study. Wound Repair and Regeneration. 2026;34(6). doi:10.1111/wrr.70216
BibTeX
@article{Qiu2026,
author = {Qiu, Le and Liu, Ying and Zhao, Yun-Peng and Zhu, Yuan-Qiang and Yan, Yun and Jiang, Zhi-Han and Liang, Xun and Liu, Sheng and Li, Feng and Sun, Ye-Xiang and Chen, Xu-Lin},
title = {Tibial Periosteal Distraction Technique Promotes Diabetic Foot Ulcer Healing and Improves Limb Preservation Rates: A Multicentre Cohort Study},
journal = {Wound Repair and Regeneration},
year = {2026},
volume = {34},
number = {6},
doi = {10.1111/wrr.70216}
}
EUVIMED